144 related articles for article (PubMed ID: 8159434)
21. Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat.
Hammond DL; Presley R; Gogas KR; Basbaum AI
J Comp Neurol; 1992 Jan; 315(2):244-53. PubMed ID: 1545011
[TBL] [Abstract][Full Text] [Related]
22. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression.
Gogas KR; Presley RW; Levine JD; Basbaum AI
Neuroscience; 1991; 42(3):617-28. PubMed ID: 1659673
[TBL] [Abstract][Full Text] [Related]
23. Diffuse noxious inhibitory controls reduce the expression of noxious stimulus-evoked Fos-like immunoreactivity in the superficial and deep laminae of the rat spinal cord.
Morgan MM; Gogas KR; Basbaum AI
Pain; 1994 Mar; 56(3):347-352. PubMed ID: 8022627
[TBL] [Abstract][Full Text] [Related]
24. Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.
Buritova J; Le Guen S; Fournié-Zaluski MC; Roques BP; Besson JM
Eur J Pain; 2003; 7(3):241-9. PubMed ID: 12725847
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
26. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine.
Rohde DS; McKay WR; Chang DS; Abbadie C; Basbaum AI
Neuroscience; 1997 Sep; 80(2):599-612. PubMed ID: 9284361
[TBL] [Abstract][Full Text] [Related]
27. Lamina-specific effects of morphine and naloxone in dorsal horn of rat spinal cord in vitro.
Magnuson DS; Dickenson AH
J Neurophysiol; 1991 Dec; 66(6):1941-50. PubMed ID: 1812227
[TBL] [Abstract][Full Text] [Related]
28. Subarachnoid morphine reduces stimulation-induced but not basal expression of preproenkephalin in rat spinal cord.
Crosby G; Marota JJ; Goto T; Uhl GR
Anesthesiology; 1994 Nov; 81(5):1270-6. PubMed ID: 7978486
[TBL] [Abstract][Full Text] [Related]
29. The novel analgesic and high-efficacy 5-HT1A receptor agonist, F 13640 induces c-Fos protein expression in spinal cord dorsal horn neurons.
Buritova J; Tarayre JP; Besson JM; Colpaert F
Brain Res; 2003 Jun; 974(1-2):212-21. PubMed ID: 12742639
[TBL] [Abstract][Full Text] [Related]
30. Anticonvulsants suppress c-Fos protein expression in spinal cord neurons following noxious thermal stimulation.
Tölle TR; Castro-Lopes JM; Schadrack J; Evan G; Zieglgänsberger W
Exp Neurol; 1995 Apr; 132(2):271-8. PubMed ID: 7789465
[TBL] [Abstract][Full Text] [Related]
31. Superficial dorsal horn neurons identified by intracutaneous histamine: chemonociceptive responses and modulation by morphine.
Jinks SL; Carstens E
J Neurophysiol; 2000 Aug; 84(2):616-27. PubMed ID: 10938290
[TBL] [Abstract][Full Text] [Related]
32. Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone.
Gouarderes C; Jhamandas K; Cridland R; Cros J; Quirion R; Zajac JM
Neuroscience; 1993 Jun; 54(3):799-807. PubMed ID: 7687333
[TBL] [Abstract][Full Text] [Related]
33. Electroacupuncture modifies the expression of c-fos in the spinal cord induced by noxious stimulation.
Lee JH; Beitz AJ
Brain Res; 1992 Apr; 577(1):80-91. PubMed ID: 1521149
[TBL] [Abstract][Full Text] [Related]
34. Modulated expression of c-Fos in the spinal cord following noxious thermal stimulation of monoarthritic rats.
Schadrack J; Castro-Lopes JM; Avelino A; Zieglgänsberger W; Tölle TR
J Neurosci Res; 1998 Jul; 53(2):203-13. PubMed ID: 9671977
[TBL] [Abstract][Full Text] [Related]
35. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
[TBL] [Abstract][Full Text] [Related]
36. Expression of nitric oxide synthase and colocalisation with Jun, Fos and Krox transcription factors in spinal cord neurons following noxious stimulation of the rat hindpaw.
Herdegen T; Rüdiger S; Mayer B; Bravo R; Zimmermann M
Brain Res Mol Brain Res; 1994 Mar; 22(1-4):245-58. PubMed ID: 7516994
[TBL] [Abstract][Full Text] [Related]
37. [Increased expression of formalin-induced Fos and NADPH-d positive neurons in the spinal cord of morphine-tolerant rats].
Cao JL; Zeng YM; Zhang LC; Duan SM
Sheng Li Xue Bao; 2000 Jun; 52(3):235-8. PubMed ID: 11956571
[TBL] [Abstract][Full Text] [Related]
38. Cholecystokinin B receptor antagonism enhances the ability of a low dose of morphine to reduce c-Fos expression in the spinal cord of the rat.
Chapman V; Honoré P; Buritova J; Besson JM
Neuroscience; 1995 Aug; 67(3):731-9. PubMed ID: 7675199
[TBL] [Abstract][Full Text] [Related]
39. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
Chapman V; Buritova J; Honoré P; Besson JM
J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
[TBL] [Abstract][Full Text] [Related]
40. Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist.
Tsou K; Lowitz KA; Hohmann AG; Martin WJ; Hathaway CB; Bereiter DA; Walker JM
Neuroscience; 1996 Feb; 70(3):791-8. PubMed ID: 10627219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
